BEAM BEAM THERAPEUTICS INC Product Launches 8-K Filing 2024 - Clinical Trial Updates Beam Therapeutics announced the acceptance of abstracts for presentation at the upcoming American Society of Hematology Annual Meeting, highlighting initial data from its clinical trials for sickle cell disease and T-cell leukemia treatments.Get access to all SEC 8-K filings of the BEAM THERAPEUTICS INC